Author

Berretta Massimiliano

National Cancer Institute CRO - Cited by 10,200 - Oncology - cancer

Biography

Dr. Berretta Massimiliano is an Associate professor in the Department of Medical Oncology, National Cancer Institute IRCCS, Italy. His study interests major on Medical Oncology. In recent years, he has studied Oncology, carcinoma cells. Currently , Dr. Massimiliano is the author/editors/reviewer in several international journals. He published 20 articles in many journals and the articles are informative and got good citations.
Title
Cited by
Year
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
JJ Swen, CH van der Wouden, LEN Manson, H Abdullah-Koolmees, ...The Lancet 401 (10374), 347-356, 2023202
50
2023
Cholesterol metabolic reprogramming in cancer and its pharmacological modulation as therapeutic strategy
I Giacomini, F Gianfanti, MA Desbats, G Orso, M Berretta, T Prayer-Galetti, ...Frontiers in oncology 11, 682911, 2021202
40
2021
Polydatin reduces cardiotoxicity and enhances the anticancer effects of sunitinib by decreasing pro-oxidative stress, pro-inflammatory cytokines, and NLRP3 inflammasome expression
V Quagliariello, M Berretta, S Buccolo, M Iovine, A Paccone, E Cavalcanti, ...Frontiers in oncology 11, 680758, 2021202
26
2021
SARS-CoV-2 related paediatric acute-onset neuropsychiatric syndrome
P Pavone, M Ceccarelli, S Marino, D Caruso, R Falsaperla, M Berretta, ...The Lancet Child & Adolescent Health 5 (6), e19-e21, 2021202
25
2021
Interleukin-1 blocking agents as promising strategy for prevention of anticancer drug-induced cardiotoxicities: possible implications in cancer patients with COVID-19.
V Quagliariello, A Paccone, M Iovine, E Cavalcanti, M Berretta, C Maurea, ...European Review for Medical & Pharmacological Sciences 25 (), 202
21
2021
Microsatellite instability: from the implementation of the detection to a prognostic and predictive role in cancers
M Amato, R Franco, G Facchini, R Addeo, F Ciardiello, M Berretta, G Vita, ...International Journal of Molecular Sciences 23 (15), 8726, 222
20
2022
Incidence of skin cancer in patients with chronic inflammatory cutaneous diseases on targeted therapies: a systematic review and meta-analysis of observational studies
S Crisafulli, L Bertino, A Fontana, F Calapai, Y Ingrasciotta, M Berretta, ...Frontiers in oncology , 687432, 2021202
11
2021
Neoplastic Implications in Patients Suffering from Hidradenitis Suppurativa under Systemic Treatments
F Li Pomi, L Macca, A Motolese, Y Ingrasciotta, M Berretta, C GuarneriBiomedicines (11), 154, 2021202
9
2021
The multiple effects of vitamin D against chronic diseases: From reduction of lipid peroxidation to updated evidence from clinical studies
M Berretta, V Quagliariello, A Bignucolo, S Facchini, N Maurea, ...Antioxidants 11 (6), 100, 2022202
9
2022
Patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) greatly improved fatigue symptoms when treated with oxygen-ozone autohemotherapy
U Tirelli, M Franzini, L Valdenassi, S Pandolfi, M Berretta, G Ricevuti, ...Journal of Clinical Medicine 11 (1), 29, 2021202
7
2021
The role of immunotherapy in a tolerogenic environment: Current and future perspectives for hepatocellular carcinoma
L Montella, F Sarno, A Ambrosino, S Facchini, M D’Antò, MM Laterza, ...Cells 10 (8), 1909, 2021202
6
2021
Cognitive function in long-term lymphoma survivors: relationship between subjective reports and objective assessments and with quality of life
B Muzzatti, N Cattaruzza, M Piccinin, C Flaiban, G Agostinelli, M Berretta, ...Psychology, Health & Medicine 2 (8), 98-979, 2021202
6
2021
Liver Transplantation for HCC in HIV-Infected Patients: Long-Term Single-Center Experience
GP Guerrini, M Berretta, G Guaraldi, P Magistri, G Esposito, R Ballarin, ...Cancers 13 (18), 4727, 2021202
6
2021
Clinical Evidence of Interaction Between Nutraceutical Supplementation and Platinum-Based Chemotherapy
V Cocetta, M Tinazzi, I Giacomini, B Rosato, E Ragazzi, M Berretta, ...Current Medicinal Chemistry 30 (19), 2141-214, 2023202
6
2023
The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities
E Franzese, SD Falco, MM Laterza, L Montella, S Facchini, C Liguori, ...Future Science OA 7 (6), FSO70, 2021202
5
2021
Chemotherapy-Induced Hepatotoxicity in HIV Patients
S Bressan, A Pierantoni, S Sharifi, S Facchini, V Quagliariello, M Berretta, ...Cells 10 (11), 2871, 2021202
5
2021
Improved survival and quality of life through an integrative, multidisciplinary oncological approach: pathophysiological analysis of four clinical cancer cases and review of …
M Berretta, A Morra, R Taibi, F Monari, N Maurea, M Ippolito, U Tirelli, ...Frontiers in Pharmacology 13, 867907, 2022202
5
2022
Evaluation of concomitant use of anticancer drugs and herbal products: from interactions to Synergic Activity
M Berretta, L Dal Lago, M Tinazzi, A Ronchi, G La Rocca, L Montella, ...Cancers 14 (21), 203, 2022202
5
2022
Combination of Spirulina platensis, Ganoderma lucidum and Moringa oleifera Improves Cardiac Functions and Reduces Pro-Inflammatory Biomarkers in …
V Quagliariello, MG Basilicata, G Pepe, R De Anseris, A Di Mauro, ...Journal of cardiovascular development and disease 9 (12), 423, 2022202
5
2022
The multiplicity of Argonaute complexes in mammalian cells
M Mauro, M Berretta, G Palermo, V Cavalieri, G La RoccaJournal of Pharmacology and Experimental Therapeutics 384 (1), 1-9, 2023202
5
2023

Referred From: https://scholar.google.com/citations?hl=en&user=1uVgTpkAAAAJ

Cited by
Citations 10200
h-index 53
i10-index 228
Recommended Journals
Open Access Journals